Heimdall Insights

Global Opioid-Induced Constipation Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Opioid-Induced Constipation Market was valued at $3.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.5% CAGR, to an estimated market size of $4.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global opioid-induced constipation (OIC) market comprises pharmaceutical therapies and targeted medications, such as peripherally acting mu-opioid receptor antagonists (PAMORAs), designed to treat gastrointestinal dysfunction resulting from the use of opioid analgesics for chronic non-cancer and cancer-related pain.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Opioid-Induced Constipation Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Segments

  • PAMORAs
  • Chloride Channel Activators
  • Conventional Laxatives & Others